Next Article in Journal
TMS Seeded Diffusion Tensor Imaging Tractography Predicts Permanent Neurological Deficits
Next Article in Special Issue
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Previous Article in Journal
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
Previous Article in Special Issue
Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
 
 
Article
Peer-Review Record

STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death

Cancers 2022, 14(2), 339; https://doi.org/10.3390/cancers14020339
by Janina Remy 1,†, Benedikt Linder 1,†, Ulrike Weirauch 2, Bryan W. Day 3, Brett W. Stringer 4, Christel Herold-Mende 5, Achim Aigner 2, Knut Krohn 6 and Donat Kögel 1,7,8,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3:
Cancers 2022, 14(2), 339; https://doi.org/10.3390/cancers14020339
Submission received: 16 December 2021 / Accepted: 30 December 2021 / Published: 11 January 2022
(This article belongs to the Special Issue Targeted Therapies for the Treatment of Glioblastoma)

Round 1

Reviewer 1 Report

The manuscript can be accepted for publication in present form.

Reviewer 2 Report

The authors have addressed the issues raised during review of the original submission

Reviewer 3 Report

The authors have addressed all my comments and have solved all of them, including new assays / results that add much quality to the paper. They have further adequately addressed my comments that are not followed up with new results. Therefore, all concerns have been solved, and this excellent and impressive piece of work can be published without further revisions.

Back to TopTop